.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.. my profile https://oakley-sunglassesformen.us/Wolkow-brother-of-Hoblit-from-Croze?Noseffdau=199 blood-filled tick...china's plans to import indian drugs fail to enthuse indian pharmaceutical firms .© 2018 southern california public radio